Current Location : Index >> News
News

Call for 2018 applications

Novo Nordisk Haemophilia Research Fund in China has financed 25 research projects proceed with the program in 2018. The Fund will support each of the research projects with a lump sum of pre-tax 300,000 RMB over two years.

Novo Nordisk Haemophilia Research Fund in China is now open for 201 8 applications. To submit your proposals, please follow the instructions online (http://www.novonordisk-haemophiliafund.com) by clicking on the “Submit a proposal” link. The deadline for this application is Jan.10, 2018.

The focus of the 2018 projects will be “Combining biological and pharmacological research for the benefit of haemophilia patients”. Eligible applicants should be affiliated with the scientific research institutions in China and collaborations with the scientists from Danish institutions will be especially encouraged.

Note: if applications include international collaboration on studies with human samples, the applicant may be required by Chinese regulation to submit an application for international collaboration on studies with human samples to Chinese Human Genetic Materials Management Office for approval .

Management Office

Novo Nordisk Haemophilia Research Fund in China

Ruijin Hospital

Shanghai Jiaotong University School of Medicine

197 Second Ruijin Road

Shanghai 200025

Cell phone: 13818824672 (Qiulan Ding) / 15821768419(Yinyin Chen)

Email: qiulan_ding@hotmail.com / cyy19821224@163.com

Copyright:  Novo Nordisk Haemophilia Research Fund in China

Technical support: Shanghai Yi Chao